Claire M. Fraser, Ph.D., serves as a director of BD (Becton, Dickinson and Company), a global medical technology company headquartered in Franklin Lakes, New Jersey. Dr. Fraser has been a member of the board since 2006.
Dr. Fraser was the founding director of the Institute for Genome Sciences and a Professor of Medicine and Microbiology and Immunology at the University of Maryland School of Medicine in Baltimore, Maryland from 2007 to 2024. From 1998 to 2007, she served as president and director of The Institute for Genomic Research, a not-for-profit research organization engaged in human and microbial genomics studies. Dr. Fraser serves as a director of Seres Therapeutics and is a member of the National Academy of Sciences and National Academy of Medicine. She previously served as the Chair of the Board and a director of the American Association for the Advancement of Science and also as a director of Ohana Biosciences Inc.
Dr. Fraser is an internationally recognized scientist who contributes to the Board a strong background in genomics, infectious diseases and molecular diagnostics, including the development of novel diagnostics and vaccines. She also brings considerable managerial experience in her field, having established and led two large research institutes for over 30 years, and through her experience as a director or several biotechnology companies and non-profit organizations.